Literature DB >> 20576349

All-trans retinoic acid downregulates ALK in neuroblastoma cell lines and induces apoptosis in neuroblastoma cell lines with activated ALK.

Hitoyasu Futami1, Ryuichi Sakai.   

Abstract

Recently, gene amplification and gain-of-function mutations of ALK have been found in some neuroblastoma cell lines and clinical tumor samples. We have previously reported that knockdown of ALK by RNAi induced apoptosis in neuroblastoma cells with gene amplification of ALK. We report that all-trans retinoic acid (ATRA) downregulates ALK in neuroblastoma cell lines. Downregulation of ALK protein by ATRA was accompanied by apoptosis in neuroblastoma cells with gene amplification or gain-of-function mutation of ALK but not in neuroblastoma cells without these genetic alterations. These results suggest that ALK downregulation by ATRA might lead to apoptosis in neuroblastoma cells with activated ALK.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20576349     DOI: 10.1016/j.canlet.2010.05.014

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.

Authors:  Raoud Marayati; Adele P Williams; Laura V Bownes; Colin H Quinn; Jerry E Stewart; Elizabeth Mroczek-Musulman; Venkatram R Atigadda; Elizabeth A Beierle
Journal:  J Pediatr Surg       Date:  2020-02-28       Impact factor: 2.545

2.  Changes in gene expression profiling of apoptotic genes in neuroblastoma cell lines upon retinoic acid treatment.

Authors:  Jon Celay; Idoia Blanco; Paula Lázcoz; Mirja Rotinen; Javier S Castresana; Ignacio Encío
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

3.  Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cells.

Authors:  Giorgia Mandili; Cristina Marini; Franco Carta; Cristina Zanini; Mauro Prato; Amina Khadjavi; Franco Turrini; Giuliana Giribaldi
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

4.  ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma.

Authors:  Md Kamrul Hasan; Asmaa Nafady; Atsushi Takatori; Satoshi Kishida; Miki Ohira; Yusuke Suenaga; Shamim Hossain; Jesmin Akter; Atsushi Ogura; Yohko Nakamura; Kenji Kadomatsu; Akira Nakagawara
Journal:  Sci Rep       Date:  2013-12-20       Impact factor: 4.379

Review 5.  Neuroblastoma treatment in the post-genomic era.

Authors:  Maria Rosaria Esposito; Sanja Aveic; Anke Seydel; Gian Paolo Tonini
Journal:  J Biomed Sci       Date:  2017-02-08       Impact factor: 8.410

6.  Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experiments.

Authors:  Ali Rihani; Tom Van Maerken; Filip Pattyn; Gert Van Peer; Anneleen Beckers; Sara De Brouwer; Candy Kumps; Evelien Mets; Joni Van der Meulen; Pieter Rondou; Carina Leonelli; Pieter Mestdagh; Frank Speleman; Jo Vandesompele
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

7.  CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells.

Authors:  Namrata Chaudhari; Priti Talwar; Christian Lefebvre D'hellencourt; Palaniyandi Ravanan
Journal:  Front Mol Neurosci       Date:  2017-09-26       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.